Research Article

The Role of von Willebrand Factor Antigen in Predicting Survival of Patients with HBV-Related Cirrhosis

Table 1

Clinical characteristics of patients at the time of enrolment.

VariableOverall (N = 228)vWF-Ag <1925 U/mL (N = 140)vWF-Ag ≥1925 U/mL (N = 88)P value

vWF-Ag (U/mL)1738 (1448–2102)1502 (1257–1687)2220 (2065–2306)<0.001
Age (year)56 (51–59)55 (51–58)56 (52–59)0.172
Female76 (33.3%)40 (28.6%)36 (40.9%)0.054
BMI (kg/m2)21.85 (20.33–23.44)21.95 (20.71–23.53)21.78 (19.79–23.32)0.156
MELD9.90 (7.90–12.96)9.41 (7.42–12.27)10.84 (9.04–15.00)<0.001
CTP stage0.171
 Stage A47 (20.6%)33 (23.6%)14 (15.9%)
 Stage B129 (56.6%)80 (57.1%)49 (55.7%)
 Stage C52 (22.8%)27 (19.3%)25 (28.4%)
Laboratory test
 Albumin (g/L)34.10 (31.20–35.62)34.10 (31.40–35.42)34.40 (30.78–35.90)0.872
 INR1.24 (1.10–1.35)1.20 (1.08–1.31)1.29 (1.13–1.44)0.006
 ALT (U/L)24 (18–39)24 (18–37)25 (17–42)0.961
 AST (U/L)42 (28–60)40 (28–51)47 (28–66)0.263
 TB (umol/L)35.00 (18.00–62.00)34.50 (17.50–53.25)36.50 (18.00–92.75)0.003
 TCH (mmol/L)2.84 (2.26–3.48)2.88 (2.29–3.56)2.79 (2.24–3.42)0.155
 UN (mmol/L)5.70 (4.20–7.30)5.60 (4.38–7.00)5.70 (3.98–7.60)0.248
 Creatinine (umol/L)65 (56–81)67 (57–82)63 (54–76)0.414
 LDH (U/L)186 (152–229)189 (154–230)185 (149–217)0.976
 Leucocytes (109/L)3.70 (2.50–5.93)3.85 (2.30–6.10)3.50 (2.60–5.30)0.959
 CRP (mg/L)8.10 (2.60–20.72)7.55 (2.45–19.28)11.55 (3.25–20.85)0.942
 Hemoglobin (g/L)102 (84–118)104 (84–118)95 (81–115)0.308
 D-dimer (μg/L)2282 (976–4902)2171 (928–4564)2888 (1153–5945)0.056
 PLT (109/L)63 (35–116)63 (37–113)63 (34–120)0.663
 Fibrinogen (g/L)1.69 (1.11–2.26)1.66 (1.12–2.46)1.73 (1.08–2.11)0.082
 HBV DNA (log10 IU/mL)7.44 (6.05–8.01)7.44 (5.97–8.00)7.40 (6.41–8.17)0.551
 O blood group84 (36.84%)64 (45.71%)20 (22.73%)<0.001

vWF-Ag, von Willebrand factor antigen; BMI, body mass index; CTP, Child–Turcotte–Pugh; INR, international normalized ratio; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TB, total bilirubin; TCH, total cholesterol; UN, urea nitrogen LDH, lactic dehydrogenase; CRP, C-reactive protein; PLT, platelet count; HBV, hepatitis B virus.